|
Delayed
NSE India S.E.
06:05:07 2026-11-03 am EST
|
5-day change | 1st Jan Change | ||
| 2,408.00 INR | +1.09% |
|
+6.28% | +18.32% |
| Oct. 29 | Glenmark Pharmaceuticals Inc. USA Inaugurates Allentown Distribution Center | CI |
| Sep. 11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| Market Cap | 672B 7.1B 6.34B 5.82B 5.29B 9.92B 10.12B 69.48B 28.01B 355B 26.65B 26.08B 1,121B | P/E 2027 * |
29.1x | P/E 2028 * | 24x |
|---|---|---|---|---|---|
| Enterprise Value | 636B 6.72B 6B 5.51B 5.01B 9.39B 9.58B 65.79B 26.52B 336B 25.23B 24.69B 1,061B | EV / Sales 2027 * |
3.76x | EV / Sales 2028 * | 3.34x |
| Free-Float |
51.04% | Yield 2027 * |
0.16% | Yield 2028 * | 0.17% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| GLENMARK | Delayed |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +1.09% | ||
| 1 week | +6.28% | ||
| Current month | +4.75% | ||
| 1 month | +4.92% | ||
| 3 months | +7.98% | ||
| 6 months | +0.60% | ||
| Current year | +18.32% |
| 1 week | 2,261.9 |  | 2,420 |
| 1 month | 2,101.6 | | 2,420 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,801.4 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 1999-12-31 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 2025-05-26 |
Indrajit Bose
PSD | President | - | 2023-09-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 57 | 2011-05-11 | |
| Director/Board Member | 86 | 2009-08-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.09% | +6.28% | +26.84% | +222.53% | 7.1B | |
| -0.46% | +10.31% | +63.52% | +143.15% | 1,257B | |
| -0.97% | +1.60% | +43.25% | +80.09% | 651B | |
| -2.05% | +0.73% | +32.47% | +101.62% | 510B | |
| -0.06% | -0.63% | +52.79% | +67.12% | 388B | |
| -0.78% | +5.51% | +72.55% | +44.25% | 366B | |
| +0.73% | +2.83% | +33.09% | +58.89% | 303B | |
| +0.06% | +8.02% | +12.02% | +34.86% | 288B | |
| -0.12% | +4.68% | +55.97% | +74.59% | 252B | |
| -0.21% | +7.34% | +42.19% | +109.69% | 211B | |
| Average | -0.06% | +4.84% | +43.47% | +93.68% | 423.38B | |
| Weighted average by Cap. | -0.38% | +5.30% | +49.20% | +93.91% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 169B 1.79B 1.6B 1.47B 1.33B 2.5B 2.55B 17.52B 7.06B 89.46B 6.72B 6.58B 283B | 187B 1.98B 1.77B 1.62B 1.47B 2.76B 2.82B 19.36B 7.8B 98.87B 7.43B 7.27B 312B |
| Net income | 23.69B 250M 223M 205M 187M 350M 357M 2.45B 987M 12.51B 939M 919M 39.5B | 28.32B 299M 267M 245M 223M 418M 426M 2.93B 1.18B 14.95B 1.12B 1.1B 47.22B |
| Net Debt | -35.75B -378M -337M -309M -281M -528M -538M -3.7B -1.49B -18.87B -1.42B -1.39B -59.6B | -47.16B -498M -445M -408M -371M -696M -710M -4.87B -1.97B -24.89B -1.87B -1.83B -78.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-03 | ₹2,408.00 | +1.09% | 930,049 |
| 26-11-02 | ₹2,382.00 | +3.62% | 1,549,673 |
| 26-10-30 | ₹2,298.70 | -1.72% | 428,887 |
| 26-10-29 | ₹2,339.00 | +1.70% | 232,396 |
| 26-10-28 | ₹2,300.00 | +1.51% | 455,830 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
